{
    "body": "Are optogenetics tools used in the study and treatment of epilepsy?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24491965", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25108607", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23871610", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19581573", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25710834", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24965021", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25303540", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25678887", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22698957", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23340416", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24005292", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23637949", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25451697", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24573293", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23143518", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22890709", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24590406", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23406911"
    ], 
    "ideal_answer": [
        "Using optogenetics tools it is possible to begin to address some of the fundamental unanswered questions in epilepsy, to dissect epileptic neuronal circuits and to develop new intervention strategies."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004827", 
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D062308"
    ], 
    "type": "yesno", 
    "id": "56e0797451531f7e3300000f", 
    "snippets": [
        {
            "offsetInBeginSection": 246, 
            "offsetInEndSection": 596, 
            "text": "The emerging revolutionary technique of optogenetics enables manipulation of the activity of specific neuronal populations in vivo with exquisite spatiotemporal resolution using light. We used optogenetic approaches to test the role of hippocampal excitatory neurons in the lithium-pilocarpine model of acute elicited seizures in awake behaving rats.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23637949", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 130, 
            "offsetInEndSection": 267, 
            "text": "This chapter focuses on the development of optogenetics and on-demand technologies for the study of epilepsy and the control of seizures.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 766, 
            "offsetInEndSection": 946, 
            "text": "We then turn to the use of optogenetics, including on-demand optogenetics in the study of epilepsies, which highlights the powerful potential of optogenetics for epilepsy research.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 177, 
            "text": "Optogenetic techniques provide powerful tools for bidirectional control of neuronal activity and investigating alterations occurring in excitability disorders, such as epilepsy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24573293", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 619, 
            "offsetInEndSection": 1019, 
            "text": " Therefore, one could optogenetically activate specific or a mixed population of interneurons and dissect their selective or concerted inhibitory action on principal cells. We chose to explore a conceptually novel strategy involving simultaneous activation of mixed populations of interneurons by optogenetics and study their impact on ongoing epileptiform activity in mouse acute hippocampal slices.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24573293", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1486, 
            "offsetInEndSection": 1762, 
            "text": "Our data suggest that global optogenetic activation of mixed interneuron populations is a more effective approach for development of novel therapeutic strategies for epilepsy, but the initial action potential generation in principal neurons needs to be taken in consideration.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24573293", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 994, 
            "offsetInEndSection": 1383, 
            "text": "Recently, a number of experiments have explored the treatments for epilepsy with optogenetic control of neurons. Here, we discuss the possibility that an optogenetic approach could be used to control the release of gliotransmitters and improve astrocyte function such as glutamate and K(+) uptake, and thereby offer a potential strategy to investigate and treat astrocyte-related epilepsy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25451697", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 253, 
            "offsetInEndSection": 637, 
            "text": "Optogenetic and designer receptor technologies provide unprecedented and much needed specificity, allowing for spatial, temporal and cell type-selective modulation of neuronal circuits. Using such tools, it is now possible to begin to address some of the fundamental unanswered questions in epilepsy, to dissect epileptic neuronal circuits and to develop new intervention strategies. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25710834", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 941, 
            "offsetInEndSection": 1121, 
            "text": "We then turn to the use of optogenetics, including on-demand optogenetics in the study of epilepsies, which highlights the powerful potential of optogenetics for epilepsy research.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 655, 
            "offsetInEndSection": 819, 
            "text": "Moreover, optogenetics may be considered for developing potential treatment strategies for brain diseases, particularly for excitability disorders such as epilepsy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22698957", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 266, 
            "offsetInEndSection": 403, 
            "text": "This chapter focuses on the development of optogenetics and on-demand technologies for the study of epilepsy and the control of seizures.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 88, 
            "text": "How might novel technologies such as optogenetics lead to better treatments in epilepsy?", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 103, 
            "text": "WONOEP appraisal: optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25303540", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1537, 
            "offsetInEndSection": 1675, 
            "text": "Finally, optogenetic tools allow rapid and reversible suppression of epileptic electroencephalography (EEG) activity upon photoactivation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25303540", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1125, 
            "offsetInEndSection": 1356, 
            "text": "Our data suggest that epileptiform activity in the hippocampus caused by impaired inhibition may be controlled by optogenetic silencing of principal neurons and potentially can be developed as an alternative treatment for epilepsy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24491965", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 115, 
            "text": "Seizure suppression by high frequency optogenetic stimulation using in vitro and in vivo animal models of epilepsy.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25108607", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 178, 
            "text": "Optogenetic techniques provide powerful tools for bidirectional control of neuronal activity and investigating alterations occurring in excitability disorders, such as epilepsy. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24573293", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 642, 
            "offsetInEndSection": 947, 
            "text": "We first discuss the benefits and caveats to using optogenetic approaches and recent advances in optogenetics related tools. We then turn to the use of optogenetics, including on-demand optogenetics in the study of epilepsies, which highlights the powerful potential of optogenetics for epilepsy research.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25012388", 
            "endSection": "abstract"
        }
    ]
}